Drug Abuse & Dependence
JOINN has filed the most amounts of carcinogenicity study data to the Chinese NMPA and US FDA among all other Chinese CROs. Protocols for carcinogenicity studies are designed according to the government oversight guidelines (NMPA, FDA, ICH, EPA, OECD and EU) and are conducted in full compliance with GLP standards. We have veteran pathological diagnostic team and abundant historical database of carcinogenicity studies. JOINN has established credibility and excellent track record of acceptance of the carcinogenicity study data by USFDA and Chinese NMPA.
GLP Services
Autonomous Administration Test
Conditioned Place Preference/Aversion
Behavioral Sensitization Test
Drug Identification Test
Natural Withdrawal Test
Urgent Withdrawal Test
Administration Route
Except for the autonomous drug administration trial, which is only suitable for intravenous drug administration, other trial items can be suitable for oral, subcutaneous, muscular, intravenous, abdominal, and local drug administration, etc.